Abstract
Systemic Lupus Erythematosus (SLE) is a chronic and multisystemic autoimmune disease, with variable prognosis and course. Despite significant advances in the treatment and prognosis of SLE, high morbidity and mortality are still observed in this population. Frailty, a condition that confers greater vulnerability to an individual, is closely related to higher mortality and adverse health e…